Your browser doesn't support javascript.
Onychomadesis in a COVID-19 patient.
Ivanova, Zlatina Georgieva; Aleksiev, Teodor Ivanov; Dobrev, Hristo Petrov.
  • Ivanova ZG; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria.
  • Aleksiev TI; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria.
  • Dobrev HP; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria. hristo_dobrev@yahoo.com.
Wien Med Wochenschr ; 2022 Nov 28.
Article in English | MEDLINE | ID: covidwho-2128757
ABSTRACT
We report the case of a 67-year-old woman who developed onychomadesis on 9 of her fingers 2 months after recovering from COVID-19, with subsequent full nail regrowth after 4 months. The development of onychomadesis in COVID-19 is probably related to inhibition of nail proliferation due to fever, direct viral damage, or an inflammatory process associated with endothelial damage and obliterative microangiopathy in the nail matrix area. Clinicians should be aware of nail changes and actively seek them out in patients with COVID-19.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: S10354-022-00988-1

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: S10354-022-00988-1